<DOC>
	<DOCNO>NCT00826111</DOCNO>
	<brief_summary>The study examine effect add sleep aid eszopiclone Lexapro mood level neurotransmitter glutamate , glutamine , GABA woman depression , anxiety , insomnia . Specifically , objective determine role glutamate , glutamine , GABA mediate response combine treatment . The hypothesis level glutamine glutamate increase woman receive eszopiclone compare receive placebo . The antidepressant effect medication combination effect sleep status also assess .</brief_summary>
	<brief_title>The Effects Eszopiclone Lexapro Prefrontal Glutamate GABA Depression With Anxiety Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Eszopiclone</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Female age 18 55 year regularly menstruate . Meets DSMIV criterion unipolar major depression . Insomnia severity index score &gt; 10 . Hamilton Anxiety scale score &gt; 15 . Hamilton Depression scale score &gt; 17 . Capable provide informed consent . Has establish residence phone . Meets DSMIV criterion schizophrenia , schizoaffective disorder axis I II diagnosis except comorbid anxiety disorder insomnia . Actively abuse substance alcohol ; meet DSMIV criterion substance dependence past month . Pregnancy . Use benzodiazepines sedativehypnotics , beta blocker , calcium channel blocker , antidepressant , antipsychotic medication , lithium medication opinion investigator could alter glutamate GABA activity brain . A medical condition , opinion investigator could possibly affect individual 's brain level Glu GABA . Participation research protocol include administration medication within past 3 month . Cigarette smoking . Subject know allergic sensitivity study escitalopram , eszopiclone zopiclone . Clinically significant suicidal ideation risk suicide evidence formulation plan step take act feeling . History clinically significant hepatic impairment . Subject take potent cytochrome p450 3A4 inhibitor medication ( ritonavir , nelfinavir , indinavir , erythromycin , clarithromycin , troleandomycin , ketoconazole , itraconazole ) unwilling clinically contraindicate stop medication .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Magnetic Resonance Spectroscopy</keyword>
	<keyword>Glutamate</keyword>
	<keyword>Glutamine</keyword>
	<keyword>GABA</keyword>
	<keyword>Lexapro</keyword>
	<keyword>Lunesta</keyword>
	<keyword>Escitalopram</keyword>
	<keyword>Eszopiclone</keyword>
</DOC>